Improving Outcomes in Corneal Endothelial Disease With Cell Therapy

Greg Kunst, chief executive officer, Aurion Biotech, discussed the potential of cell therapy in treating people with corneal endothelial disease around the world.

Around the Helix: Gene and Cell Therapy Company Updates - January 19, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.

Second Pivotal Trial Initiated for Wet AMD Gene Therapy

The ASCENT trial is kicking off while the ATMOSPHERE trial continues to screen patients with wet AMD.